Normally, acetaldehyde is quickly converted into less harmful substances, but impaired acetaldehyde metabolism can lead to alcohol metabolite accumulation
With recombinant technology, therapeutic peptide chains can more easily exceed 50 amino acids
MOTS-c is a mitochondrial-derived hexadecapeptide (16 amino acids, MT-RNR1 encoded), available in 10mg, 20mg, or 40mg lyophilized vials
This product may contain aluminum, which may accumulate to toxic levels in patients with renal dysfunction or during high-dose or long-term treatment
Certain questions may arise: The first concerns whether the intentional lowering of the local intestinal pH by using acid will degrade the peptide
Suspected side effects can be reported via the MHRA Yellow Card Scheme